It is which option is medically appropriate, tolerable, accessible, and sustainable for the individual patient
Call or text 312.312.7873 or book your appointment online to get started
Lifestyle changes Weight loss medications work best when paired with a diet and exercise program, and the VA requires patients to have an existing program that includes both before theyll cover Wegovy
Semaglutide, as well as other weight loss medications such as liraglutide and tirzepatide, are GLP-1 receptor agonists
This distinction matters clinically: Wegovy's approved dosing reaches a higher target dose of 2.4 mg weekly, compared to Ozempic's typical 1.0 mg, which translates into greater average weight loss in clinical trials
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists